Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6143781 | American Journal of Obstetrics and Gynecology | 2016 | 25 Pages |
Abstract
Cervical length screening and treatment with progesterone is a not a dominant, cost-effective strategy unless progesterone is more effective than has been suggested by available data for US women. Until future trials demonstrate greater progesterone efficacy, and effectiveness studies confirm a benefit from screening and treatment, the cost-effectiveness of universal cervical length screening in the United States remains questionable.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Siddharth MBBS, MPH, Meredith PhD, MSPH, Rodney K. MD, MS, John MD, MSPH,